| 1.3 |
3.8 |
GO:0060364 |
frontal suture morphogenesis(GO:0060364) |
| 1.2 |
12.3 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 1.1 |
4.6 |
GO:1900145 |
regulation of nodal signaling pathway involved in determination of left/right asymmetry(GO:1900145) regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900175) positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 1.1 |
3.4 |
GO:0060489 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 1.1 |
4.3 |
GO:0003360 |
brainstem development(GO:0003360) |
| 1.1 |
3.2 |
GO:0035878 |
nail development(GO:0035878) |
| 1.0 |
4.2 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 1.0 |
3.1 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 1.0 |
3.0 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 0.9 |
0.9 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.9 |
2.7 |
GO:0035604 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) squamous basal epithelial stem cell differentiation involved in prostate gland acinus development(GO:0060529) |
| 0.9 |
3.6 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.9 |
2.7 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.9 |
0.9 |
GO:0070094 |
positive regulation of glucagon secretion(GO:0070094) |
| 0.9 |
7.8 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.9 |
4.3 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.8 |
2.5 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.8 |
4.1 |
GO:0021965 |
spinal cord ventral commissure morphogenesis(GO:0021965) |
| 0.8 |
2.4 |
GO:0003150 |
muscular septum morphogenesis(GO:0003150) |
| 0.8 |
3.2 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.8 |
5.5 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.8 |
2.3 |
GO:0032877 |
positive regulation of DNA endoreduplication(GO:0032877) |
| 0.8 |
1.5 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 0.7 |
2.2 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.7 |
0.7 |
GO:0072204 |
cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 0.7 |
2.2 |
GO:0003289 |
atrial septum primum morphogenesis(GO:0003289) |
| 0.7 |
4.4 |
GO:0060024 |
rhythmic synaptic transmission(GO:0060024) |
| 0.7 |
2.2 |
GO:0021893 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) |
| 0.7 |
2.1 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 0.7 |
2.8 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.7 |
3.5 |
GO:0006447 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 0.7 |
4.2 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.7 |
3.4 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.7 |
0.7 |
GO:0043974 |
histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
| 0.7 |
2.0 |
GO:0045819 |
positive regulation of glycogen catabolic process(GO:0045819) |
| 0.7 |
3.3 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.6 |
1.3 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.6 |
5.6 |
GO:0046499 |
S-adenosylmethioninamine metabolic process(GO:0046499) |
| 0.6 |
0.6 |
GO:0060423 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
| 0.6 |
2.5 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.6 |
1.2 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.6 |
0.6 |
GO:0060994 |
regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.6 |
2.4 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.6 |
0.6 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.6 |
2.3 |
GO:0086069 |
bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.6 |
1.2 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.6 |
1.7 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.6 |
3.9 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.6 |
0.6 |
GO:1901187 |
regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.6 |
2.8 |
GO:0060842 |
arterial endothelial cell differentiation(GO:0060842) |
| 0.6 |
1.7 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.5 |
0.5 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.5 |
0.5 |
GO:0051252 |
regulation of RNA metabolic process(GO:0051252) |
| 0.5 |
1.6 |
GO:0046022 |
regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.5 |
1.6 |
GO:0045976 |
negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
| 0.5 |
1.6 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.5 |
2.1 |
GO:0007223 |
Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.5 |
1.0 |
GO:0032650 |
regulation of interleukin-1 alpha production(GO:0032650) positive regulation of interleukin-1 alpha production(GO:0032730) |
| 0.5 |
3.6 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.5 |
2.6 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.5 |
1.5 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.5 |
1.0 |
GO:2001027 |
negative regulation of endothelial cell chemotaxis(GO:2001027) |
| 0.5 |
1.0 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.5 |
1.5 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.5 |
0.5 |
GO:0070571 |
negative regulation of neuron projection regeneration(GO:0070571) |
| 0.5 |
1.5 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) |
| 0.5 |
1.4 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.5 |
3.8 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.5 |
1.9 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.5 |
1.4 |
GO:0000059 |
protein import into nucleus, docking(GO:0000059) |
| 0.5 |
1.8 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.4 |
4.0 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.4 |
1.3 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.4 |
1.3 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.4 |
1.8 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.4 |
2.7 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.4 |
0.4 |
GO:0003338 |
metanephros morphogenesis(GO:0003338) |
| 0.4 |
1.3 |
GO:0097402 |
neuroblast migration(GO:0097402) |
| 0.4 |
3.9 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.4 |
1.7 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.4 |
0.4 |
GO:0010571 |
positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
| 0.4 |
3.0 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.4 |
6.4 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.4 |
0.4 |
GO:0045915 |
positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
| 0.4 |
1.7 |
GO:0030916 |
otic vesicle formation(GO:0030916) |
| 0.4 |
0.4 |
GO:0072205 |
metanephric collecting duct development(GO:0072205) |
| 0.4 |
4.1 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.4 |
2.5 |
GO:0060242 |
contact inhibition(GO:0060242) |
| 0.4 |
2.5 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.4 |
1.2 |
GO:1904395 |
positive regulation of receptor clustering(GO:1903911) regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904393) positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
| 0.4 |
1.2 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.4 |
0.4 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.4 |
1.6 |
GO:0014835 |
myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 0.4 |
0.8 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.4 |
3.2 |
GO:1900262 |
regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.4 |
0.8 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.4 |
1.9 |
GO:0001840 |
neural plate development(GO:0001840) |
| 0.4 |
1.2 |
GO:0000087 |
mitotic M phase(GO:0000087) |
| 0.4 |
1.5 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.4 |
0.8 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.4 |
0.4 |
GO:0014834 |
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.4 |
1.1 |
GO:0072356 |
chromosome passenger complex localization to kinetochore(GO:0072356) |
| 0.4 |
1.8 |
GO:1904690 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.4 |
2.5 |
GO:0070561 |
vitamin D receptor signaling pathway(GO:0070561) |
| 0.4 |
1.1 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.4 |
1.1 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.4 |
3.2 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.4 |
1.1 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.4 |
1.1 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.4 |
0.4 |
GO:0009147 |
pyrimidine nucleoside triphosphate metabolic process(GO:0009147) |
| 0.4 |
1.4 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 |
2.1 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.3 |
2.1 |
GO:0060836 |
lymphatic endothelial cell differentiation(GO:0060836) |
| 0.3 |
0.3 |
GO:0060029 |
convergent extension involved in organogenesis(GO:0060029) |
| 0.3 |
1.4 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.3 |
1.4 |
GO:1900451 |
positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
| 0.3 |
1.4 |
GO:0070858 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.3 |
1.0 |
GO:1902396 |
protein localization to bicellular tight junction(GO:1902396) |
| 0.3 |
0.7 |
GO:1904192 |
cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
| 0.3 |
1.4 |
GO:0072675 |
osteoclast fusion(GO:0072675) |
| 0.3 |
0.7 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.3 |
0.3 |
GO:1902263 |
apoptotic process involved in embryonic digit morphogenesis(GO:1902263) |
| 0.3 |
1.0 |
GO:0009177 |
deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
| 0.3 |
3.1 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.3 |
0.3 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.3 |
1.0 |
GO:0046370 |
fructose biosynthetic process(GO:0046370) |
| 0.3 |
1.0 |
GO:0018107 |
peptidyl-threonine phosphorylation(GO:0018107) |
| 0.3 |
0.7 |
GO:0014842 |
regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
| 0.3 |
1.3 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.3 |
1.0 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.3 |
2.9 |
GO:0090178 |
regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) |
| 0.3 |
1.0 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.3 |
1.0 |
GO:0046101 |
hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.3 |
1.0 |
GO:0006931 |
substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.3 |
0.3 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.3 |
2.2 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.3 |
0.9 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.3 |
1.6 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.3 |
2.8 |
GO:2000394 |
positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.3 |
0.9 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.3 |
0.9 |
GO:2000054 |
regulation of centromeric sister chromatid cohesion(GO:0070602) regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000053) negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
| 0.3 |
1.2 |
GO:0043490 |
malate-aspartate shuttle(GO:0043490) |
| 0.3 |
1.5 |
GO:0048133 |
germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
| 0.3 |
1.2 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.3 |
0.9 |
GO:1902498 |
regulation of protein autoubiquitination(GO:1902498) |
| 0.3 |
0.6 |
GO:0008626 |
granzyme-mediated apoptotic signaling pathway(GO:0008626) |
| 0.3 |
0.6 |
GO:1902915 |
negative regulation of protein K63-linked ubiquitination(GO:1900045) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.3 |
2.1 |
GO:0043983 |
histone H4-K12 acetylation(GO:0043983) |
| 0.3 |
0.9 |
GO:0061209 |
cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
| 0.3 |
1.2 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.3 |
0.9 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.3 |
6.8 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.3 |
3.0 |
GO:0021785 |
branchiomotor neuron axon guidance(GO:0021785) |
| 0.3 |
2.6 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.3 |
1.8 |
GO:0072513 |
positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.3 |
1.5 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.3 |
1.5 |
GO:0006207 |
'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.3 |
0.3 |
GO:2000338 |
chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
| 0.3 |
2.0 |
GO:0006344 |
maintenance of chromatin silencing(GO:0006344) |
| 0.3 |
0.6 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.3 |
0.9 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.3 |
0.6 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.3 |
0.9 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.3 |
1.4 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 |
1.7 |
GO:0090267 |
positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
| 0.3 |
1.7 |
GO:0060295 |
regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.3 |
0.8 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.3 |
0.6 |
GO:0033280 |
response to vitamin D(GO:0033280) |
| 0.3 |
3.1 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.3 |
1.1 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.3 |
1.4 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.3 |
0.3 |
GO:0051643 |
endoplasmic reticulum localization(GO:0051643) |
| 0.3 |
0.8 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.3 |
0.6 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.3 |
4.2 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.3 |
1.4 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.3 |
0.8 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.3 |
1.4 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.3 |
1.1 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.3 |
0.5 |
GO:0002069 |
columnar/cuboidal epithelial cell maturation(GO:0002069) |
| 0.3 |
2.7 |
GO:0030853 |
negative regulation of granulocyte differentiation(GO:0030853) |
| 0.3 |
0.3 |
GO:0061643 |
chemorepulsion of axon(GO:0061643) |
| 0.3 |
0.5 |
GO:1902661 |
regulation of glucose mediated signaling pathway(GO:1902659) positive regulation of glucose mediated signaling pathway(GO:1902661) |
| 0.3 |
0.8 |
GO:0021797 |
forebrain anterior/posterior pattern specification(GO:0021797) |
| 0.3 |
0.3 |
GO:0033122 |
regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.3 |
2.1 |
GO:0021592 |
fourth ventricle development(GO:0021592) |
| 0.3 |
0.3 |
GO:0030330 |
DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
| 0.3 |
0.8 |
GO:0046544 |
development of secondary male sexual characteristics(GO:0046544) |
| 0.3 |
0.3 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.3 |
0.3 |
GO:0016925 |
protein sumoylation(GO:0016925) |
| 0.3 |
1.1 |
GO:2001045 |
negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.3 |
1.0 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.3 |
1.0 |
GO:0070829 |
heterochromatin maintenance(GO:0070829) |
| 0.3 |
1.5 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.3 |
0.5 |
GO:0060221 |
retinal rod cell differentiation(GO:0060221) |
| 0.3 |
1.0 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.3 |
1.3 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.3 |
0.8 |
GO:1904996 |
positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
| 0.3 |
1.0 |
GO:0045343 |
MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
| 0.3 |
0.3 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.3 |
1.8 |
GO:0008635 |
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.3 |
0.8 |
GO:0097309 |
cap1 mRNA methylation(GO:0097309) |
| 0.3 |
0.3 |
GO:0001656 |
metanephros development(GO:0001656) |
| 0.2 |
1.2 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.2 |
1.2 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.2 |
2.7 |
GO:0000183 |
chromatin silencing at rDNA(GO:0000183) |
| 0.2 |
0.7 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 0.2 |
0.5 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.2 |
1.0 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.2 |
1.2 |
GO:0002363 |
alpha-beta T cell lineage commitment(GO:0002363) |
| 0.2 |
0.2 |
GO:1904749 |
regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.2 |
0.5 |
GO:0009174 |
UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
| 0.2 |
2.6 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.2 |
1.2 |
GO:0046601 |
positive regulation of centriole replication(GO:0046601) |
| 0.2 |
2.8 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.2 |
0.2 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.2 |
1.4 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.2 |
2.1 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
0.2 |
GO:0003263 |
cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
| 0.2 |
0.7 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 0.2 |
1.4 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.2 |
0.7 |
GO:0016115 |
terpenoid catabolic process(GO:0016115) |
| 0.2 |
0.7 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.2 |
0.9 |
GO:0002036 |
regulation of L-glutamate transport(GO:0002036) |
| 0.2 |
2.1 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.2 |
2.5 |
GO:0045974 |
miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
| 0.2 |
0.7 |
GO:0046654 |
tetrahydrofolate biosynthetic process(GO:0046654) |
| 0.2 |
3.0 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 |
3.2 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.2 |
3.9 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.2 |
0.7 |
GO:2000065 |
negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
| 0.2 |
0.2 |
GO:0072017 |
distal tubule development(GO:0072017) |
| 0.2 |
1.6 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.2 |
0.7 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.2 |
1.1 |
GO:2000325 |
regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.2 |
2.0 |
GO:0036123 |
histone H3-K9 dimethylation(GO:0036123) |
| 0.2 |
1.1 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.2 |
0.4 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.2 |
1.1 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.2 |
0.7 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.2 |
0.7 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.2 |
2.4 |
GO:0007100 |
mitotic centrosome separation(GO:0007100) |
| 0.2 |
0.7 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.2 |
0.9 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.2 |
0.2 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.2 |
0.2 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.2 |
0.6 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.2 |
0.9 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.2 |
0.9 |
GO:0072365 |
regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 0.2 |
0.6 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.2 |
0.6 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.2 |
1.7 |
GO:0070314 |
G1 to G0 transition(GO:0070314) |
| 0.2 |
0.6 |
GO:0048211 |
Golgi vesicle docking(GO:0048211) |
| 0.2 |
0.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.2 |
0.6 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.2 |
0.2 |
GO:1901536 |
regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
| 0.2 |
2.7 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 |
1.7 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.2 |
0.2 |
GO:0097694 |
establishment of RNA localization to telomere(GO:0097694) |
| 0.2 |
1.9 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 |
0.2 |
GO:1902570 |
protein localization to nucleolus(GO:1902570) |
| 0.2 |
0.6 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.2 |
0.2 |
GO:0048340 |
paraxial mesoderm morphogenesis(GO:0048340) |
| 0.2 |
2.9 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.2 |
1.0 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.2 |
0.2 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.2 |
0.2 |
GO:1904251 |
regulation of bile acid metabolic process(GO:1904251) |
| 0.2 |
0.6 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.2 |
0.8 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.2 |
0.2 |
GO:0060019 |
radial glial cell differentiation(GO:0060019) |
| 0.2 |
1.6 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.2 |
1.0 |
GO:0046599 |
regulation of centriole replication(GO:0046599) |
| 0.2 |
0.6 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.2 |
0.6 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 |
0.4 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.2 |
1.2 |
GO:1903056 |
regulation of lens fiber cell differentiation(GO:1902746) positive regulation of lens fiber cell differentiation(GO:1902748) regulation of melanosome organization(GO:1903056) |
| 0.2 |
1.2 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.2 |
0.6 |
GO:0006546 |
glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.2 |
1.0 |
GO:0071865 |
regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) |
| 0.2 |
0.8 |
GO:0097411 |
hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.2 |
1.2 |
GO:1903300 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 |
0.4 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.2 |
0.2 |
GO:0016078 |
tRNA catabolic process(GO:0016078) |
| 0.2 |
1.7 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.2 |
0.6 |
GO:0009446 |
putrescine biosynthetic process(GO:0009446) |
| 0.2 |
0.2 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 |
0.4 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.2 |
0.8 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.2 |
0.2 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.2 |
0.8 |
GO:0046125 |
pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 |
1.7 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.2 |
0.4 |
GO:0031627 |
telomeric loop formation(GO:0031627) |
| 0.2 |
0.6 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.2 |
0.8 |
GO:1903288 |
regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
| 0.2 |
0.6 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 |
0.8 |
GO:1902715 |
positive regulation of interferon-gamma secretion(GO:1902715) |
| 0.2 |
0.9 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.2 |
1.1 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.2 |
2.5 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.2 |
0.2 |
GO:0010658 |
striated muscle cell apoptotic process(GO:0010658) |
| 0.2 |
1.1 |
GO:0016576 |
histone dephosphorylation(GO:0016576) |
| 0.2 |
2.1 |
GO:0048096 |
chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 |
0.9 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.2 |
4.7 |
GO:0042059 |
negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
| 0.2 |
3.0 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.2 |
0.7 |
GO:0033563 |
dorsal/ventral axon guidance(GO:0033563) |
| 0.2 |
1.5 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.2 |
0.2 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.2 |
0.9 |
GO:0060763 |
mammary duct terminal end bud growth(GO:0060763) |
| 0.2 |
0.5 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.2 |
0.7 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.2 |
0.4 |
GO:1990086 |
lens fiber cell apoptotic process(GO:1990086) |
| 0.2 |
0.4 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.2 |
3.3 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.2 |
0.5 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.2 |
0.7 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.2 |
1.4 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.2 |
1.3 |
GO:1902965 |
protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.2 |
0.5 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.2 |
0.4 |
GO:0007350 |
blastoderm segmentation(GO:0007350) |
| 0.2 |
0.9 |
GO:0086045 |
membrane depolarization during AV node cell action potential(GO:0086045) |
| 0.2 |
5.3 |
GO:0006270 |
DNA replication initiation(GO:0006270) |
| 0.2 |
0.9 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.2 |
0.5 |
GO:0021986 |
epithalamus development(GO:0021538) habenula development(GO:0021986) |
| 0.2 |
1.6 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.2 |
0.5 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.2 |
0.5 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.2 |
0.4 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) |
| 0.2 |
0.3 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.2 |
0.5 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.2 |
1.6 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 |
0.2 |
GO:0010871 |
negative regulation of receptor biosynthetic process(GO:0010871) |
| 0.2 |
0.3 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.2 |
0.7 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.2 |
0.5 |
GO:0016332 |
establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.2 |
0.2 |
GO:0043587 |
tongue morphogenesis(GO:0043587) fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) cranial ganglion development(GO:0061550) |
| 0.2 |
0.9 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.2 |
1.0 |
GO:0098700 |
aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
| 0.2 |
0.3 |
GO:0070100 |
negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.2 |
0.3 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.2 |
1.0 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.2 |
0.3 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.2 |
0.5 |
GO:1901097 |
negative regulation of autophagosome maturation(GO:1901097) |
| 0.2 |
0.2 |
GO:0072070 |
loop of Henle development(GO:0072070) metanephric loop of Henle development(GO:0072236) |
| 0.2 |
0.9 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.2 |
1.5 |
GO:0006104 |
succinyl-CoA metabolic process(GO:0006104) |
| 0.2 |
0.9 |
GO:0003420 |
regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 0.2 |
0.5 |
GO:0006285 |
base-excision repair, AP site formation(GO:0006285) |
| 0.2 |
0.5 |
GO:0001569 |
patterning of blood vessels(GO:0001569) |
| 0.2 |
0.5 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.2 |
0.8 |
GO:0034080 |
CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.2 |
0.7 |
GO:0039703 |
viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.2 |
0.5 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.2 |
0.7 |
GO:0030576 |
Cajal body organization(GO:0030576) |
| 0.2 |
1.0 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.2 |
0.8 |
GO:0072368 |
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.2 |
1.0 |
GO:2001256 |
regulation of store-operated calcium entry(GO:2001256) |
| 0.2 |
0.5 |
GO:0021691 |
cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.2 |
0.7 |
GO:0046726 |
positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.2 |
1.2 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.2 |
0.5 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.2 |
0.5 |
GO:1904154 |
positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.2 |
0.7 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.2 |
0.3 |
GO:0035426 |
extracellular matrix-cell signaling(GO:0035426) |
| 0.2 |
0.7 |
GO:0035795 |
negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.2 |
0.5 |
GO:0048696 |
regulation of collateral sprouting in absence of injury(GO:0048696) |
| 0.2 |
0.7 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.2 |
1.1 |
GO:0033572 |
transferrin transport(GO:0033572) |
| 0.2 |
1.1 |
GO:0050716 |
positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.2 |
0.2 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.2 |
0.3 |
GO:2000780 |
negative regulation of double-strand break repair(GO:2000780) |
| 0.2 |
0.5 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.2 |
0.3 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.2 |
0.6 |
GO:1900368 |
regulation of RNA interference(GO:1900368) |
| 0.2 |
3.6 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.2 |
0.2 |
GO:1905050 |
positive regulation of metallopeptidase activity(GO:1905050) |
| 0.2 |
0.2 |
GO:0098763 |
mitotic cell cycle phase(GO:0098763) |
| 0.2 |
0.6 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.2 |
0.5 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.2 |
2.5 |
GO:0035020 |
regulation of Rac protein signal transduction(GO:0035020) |
| 0.2 |
0.2 |
GO:1902255 |
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
| 0.2 |
3.5 |
GO:0040015 |
negative regulation of multicellular organism growth(GO:0040015) |
| 0.2 |
0.2 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.2 |
1.2 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 |
1.1 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.2 |
1.2 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.2 |
0.2 |
GO:0070344 |
fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
| 0.2 |
0.6 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.2 |
1.5 |
GO:0051571 |
positive regulation of histone H3-K4 methylation(GO:0051571) |
| 0.2 |
0.3 |
GO:0090071 |
negative regulation of ribosome biogenesis(GO:0090071) |
| 0.2 |
0.8 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.2 |
0.9 |
GO:0031016 |
pancreas development(GO:0031016) |
| 0.2 |
3.3 |
GO:0044819 |
mitotic G1/S transition checkpoint(GO:0044819) |
| 0.2 |
0.5 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.2 |
0.5 |
GO:0070844 |
misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
| 0.2 |
1.2 |
GO:0016479 |
negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
| 0.2 |
0.6 |
GO:0005981 |
regulation of glycogen catabolic process(GO:0005981) |
| 0.1 |
1.3 |
GO:0070389 |
chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 |
0.7 |
GO:0044783 |
G1 DNA damage checkpoint(GO:0044783) |
| 0.1 |
0.6 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.1 |
1.0 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.1 |
0.1 |
GO:0060686 |
regulation of prostatic bud formation(GO:0060685) negative regulation of prostatic bud formation(GO:0060686) |
| 0.1 |
0.4 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.1 |
0.3 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.1 |
0.4 |
GO:0048478 |
replication fork protection(GO:0048478) |
| 0.1 |
0.3 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.1 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.1 |
0.1 |
GO:0060339 |
negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.1 |
0.1 |
GO:0010911 |
regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
| 0.1 |
0.9 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.1 |
0.1 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 |
0.4 |
GO:1902669 |
positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
| 0.1 |
1.0 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.1 |
0.7 |
GO:0090188 |
negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.1 |
0.3 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.1 |
0.8 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.1 |
0.4 |
GO:0060809 |
mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
| 0.1 |
0.1 |
GO:0038003 |
opioid receptor signaling pathway(GO:0038003) regulation of opioid receptor signaling pathway(GO:2000474) |
| 0.1 |
3.2 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.1 |
1.3 |
GO:0006337 |
nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
| 0.1 |
0.3 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.1 |
0.3 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.1 |
2.8 |
GO:2000134 |
negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.1 |
0.6 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.1 |
0.1 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.1 |
0.4 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.1 |
0.4 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.1 |
0.7 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.1 |
0.8 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.1 |
0.7 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) |
| 0.1 |
1.0 |
GO:0051231 |
mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
| 0.1 |
0.8 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.1 |
1.4 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.1 |
2.0 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.1 |
0.3 |
GO:0031860 |
telomeric 3' overhang formation(GO:0031860) |
| 0.1 |
1.9 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.1 |
0.7 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.1 |
0.5 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.1 |
0.3 |
GO:1902259 |
regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 |
0.3 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 |
0.4 |
GO:0019659 |
glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.1 |
0.7 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
0.1 |
GO:0043090 |
amino acid import(GO:0043090) |
| 0.1 |
0.1 |
GO:0039519 |
modulation by virus of host autophagy(GO:0039519) |
| 0.1 |
0.4 |
GO:0046381 |
CMP-N-acetylneuraminate metabolic process(GO:0046381) |
| 0.1 |
0.4 |
GO:1904031 |
positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.1 |
0.4 |
GO:0071374 |
cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.1 |
0.5 |
GO:0060192 |
negative regulation of lipase activity(GO:0060192) |
| 0.1 |
0.3 |
GO:0010520 |
regulation of reciprocal meiotic recombination(GO:0010520) |
| 0.1 |
0.1 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.1 |
0.7 |
GO:0030951 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.1 |
0.8 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.1 |
1.3 |
GO:0048385 |
regulation of retinoic acid receptor signaling pathway(GO:0048385) |
| 0.1 |
3.8 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.1 |
0.7 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 0.1 |
0.4 |
GO:0046061 |
dATP catabolic process(GO:0046061) |
| 0.1 |
0.4 |
GO:0033148 |
positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.1 |
0.3 |
GO:0045091 |
regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
| 0.1 |
0.3 |
GO:0051661 |
maintenance of centrosome location(GO:0051661) |
| 0.1 |
0.4 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.1 |
0.4 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.1 |
0.5 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) |
| 0.1 |
0.3 |
GO:0006154 |
adenosine catabolic process(GO:0006154) |
| 0.1 |
1.0 |
GO:0008343 |
adult feeding behavior(GO:0008343) |
| 0.1 |
0.1 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.1 |
0.4 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.1 |
0.3 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 |
0.6 |
GO:0006356 |
regulation of transcription from RNA polymerase I promoter(GO:0006356) |
| 0.1 |
1.5 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
0.3 |
GO:0010626 |
negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.1 |
2.8 |
GO:0045880 |
positive regulation of smoothened signaling pathway(GO:0045880) |
| 0.1 |
0.3 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 |
0.6 |
GO:0043922 |
negative regulation by host of viral transcription(GO:0043922) |
| 0.1 |
1.5 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) positive regulation of cell cycle G2/M phase transition(GO:1902751) |
| 0.1 |
0.5 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.1 |
0.3 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.1 |
0.9 |
GO:0002903 |
negative regulation of B cell apoptotic process(GO:0002903) |
| 0.1 |
0.1 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.1 |
0.3 |
GO:0060591 |
chondroblast differentiation(GO:0060591) |
| 0.1 |
0.8 |
GO:0051409 |
response to nitrosative stress(GO:0051409) |
| 0.1 |
0.9 |
GO:1904357 |
negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
| 0.1 |
0.8 |
GO:0071168 |
protein localization to chromatin(GO:0071168) |
| 0.1 |
0.5 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
0.4 |
GO:1990034 |
calcium ion export from cell(GO:1990034) |
| 0.1 |
0.1 |
GO:0071603 |
endothelial cell-cell adhesion(GO:0071603) |
| 0.1 |
1.5 |
GO:0006972 |
hyperosmotic response(GO:0006972) |
| 0.1 |
0.5 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.1 |
0.1 |
GO:0008354 |
germ cell migration(GO:0008354) |
| 0.1 |
0.9 |
GO:0030238 |
male sex determination(GO:0030238) |
| 0.1 |
1.2 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.1 |
0.7 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.1 |
2.3 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
1.4 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
2.4 |
GO:1902808 |
positive regulation of cell cycle G1/S phase transition(GO:1902808) |
| 0.1 |
0.5 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
2.2 |
GO:0032933 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
0.7 |
GO:0051461 |
regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
| 0.1 |
0.2 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.2 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.1 |
0.4 |
GO:0035774 |
positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.1 |
0.6 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
0.7 |
GO:1903755 |
regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.1 |
0.4 |
GO:0051352 |
negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 |
0.1 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 |
0.4 |
GO:1905206 |
positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
| 0.1 |
0.8 |
GO:0015862 |
uridine transport(GO:0015862) |
| 0.1 |
0.4 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.1 |
0.6 |
GO:0072257 |
metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.1 |
0.6 |
GO:0010944 |
negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.1 |
0.5 |
GO:0072498 |
embryonic skeletal joint development(GO:0072498) |
| 0.1 |
0.2 |
GO:1904059 |
regulation of locomotor rhythm(GO:1904059) |
| 0.1 |
0.9 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
0.5 |
GO:1901524 |
regulation of macromitophagy(GO:1901524) negative regulation of macromitophagy(GO:1901525) |
| 0.1 |
0.1 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.1 |
2.0 |
GO:0021516 |
dorsal spinal cord development(GO:0021516) |
| 0.1 |
0.3 |
GO:0097274 |
urea homeostasis(GO:0097274) |
| 0.1 |
0.5 |
GO:0031587 |
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) positive regulation of neurotrophin production(GO:0032901) |
| 0.1 |
0.8 |
GO:0048680 |
positive regulation of axon regeneration(GO:0048680) |
| 0.1 |
0.7 |
GO:0060055 |
angiogenesis involved in wound healing(GO:0060055) |
| 0.1 |
0.5 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.1 |
1.0 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.1 |
0.1 |
GO:0050688 |
regulation of defense response to virus(GO:0050688) |
| 0.1 |
0.3 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.1 |
0.3 |
GO:0042822 |
vitamin B6 metabolic process(GO:0042816) pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.1 |
0.5 |
GO:0043153 |
photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.1 |
0.5 |
GO:0034394 |
protein localization to cell surface(GO:0034394) |
| 0.1 |
0.6 |
GO:0031110 |
regulation of microtubule polymerization or depolymerization(GO:0031110) |
| 0.1 |
0.8 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.1 |
0.2 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 |
0.2 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
0.2 |
GO:0070307 |
lens fiber cell development(GO:0070307) |
| 0.1 |
0.3 |
GO:0031086 |
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 |
0.9 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 |
0.8 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.1 |
0.3 |
GO:0007171 |
activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 |
0.9 |
GO:0021891 |
olfactory bulb interneuron development(GO:0021891) |
| 0.1 |
0.8 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.3 |
GO:0030300 |
regulation of intestinal cholesterol absorption(GO:0030300) |
| 0.1 |
0.3 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 |
0.3 |
GO:0019471 |
4-hydroxyproline metabolic process(GO:0019471) |
| 0.1 |
0.7 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.5 |
GO:0031022 |
nuclear migration along microfilament(GO:0031022) |
| 0.1 |
0.5 |
GO:1900748 |
positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.1 |
0.3 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 0.1 |
0.3 |
GO:1901250 |
regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.1 |
0.1 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
0.2 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
0.1 |
GO:0061086 |
negative regulation of histone H3-K27 methylation(GO:0061086) |
| 0.1 |
0.4 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.1 |
0.2 |
GO:0010694 |
positive regulation of alkaline phosphatase activity(GO:0010694) |
| 0.1 |
1.8 |
GO:0043403 |
skeletal muscle tissue regeneration(GO:0043403) |
| 0.1 |
0.6 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.1 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.1 |
0.3 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.1 |
0.4 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.1 |
0.1 |
GO:0006901 |
vesicle coating(GO:0006901) vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) COPII-coated vesicle budding(GO:0090114) |
| 0.1 |
1.3 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
1.3 |
GO:0009263 |
deoxyribonucleotide biosynthetic process(GO:0009263) |
| 0.1 |
0.3 |
GO:1901490 |
regulation of lymphangiogenesis(GO:1901490) negative regulation of lymphangiogenesis(GO:1901491) |
| 0.1 |
2.5 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.1 |
0.6 |
GO:0061084 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.1 |
0.4 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.1 |
2.6 |
GO:0008608 |
attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.1 |
0.2 |
GO:0044793 |
negative regulation by host of viral process(GO:0044793) |
| 0.1 |
1.5 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.1 |
GO:0090309 |
positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
| 0.1 |
0.3 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.1 |
0.1 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.1 |
0.1 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.1 |
1.1 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.1 |
0.5 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.1 |
0.1 |
GO:0046824 |
positive regulation of nucleocytoplasmic transport(GO:0046824) |
| 0.1 |
0.1 |
GO:0045687 |
positive regulation of glial cell differentiation(GO:0045687) |
| 0.1 |
0.4 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.1 |
0.3 |
GO:1903912 |
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
| 0.1 |
0.1 |
GO:0006826 |
iron ion transport(GO:0006826) |
| 0.1 |
2.3 |
GO:0046856 |
phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.3 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.1 |
0.2 |
GO:0006297 |
nucleotide-excision repair, DNA gap filling(GO:0006297) |
| 0.1 |
0.3 |
GO:0042414 |
epinephrine metabolic process(GO:0042414) |
| 0.1 |
0.4 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.1 |
0.1 |
GO:0034238 |
macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) |
| 0.1 |
0.1 |
GO:0097680 |
double-strand break repair via classical nonhomologous end joining(GO:0097680) |
| 0.1 |
0.1 |
GO:0003094 |
glomerular filtration(GO:0003094) |
| 0.1 |
0.1 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.1 |
0.3 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.1 |
0.1 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.1 |
0.7 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.6 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 |
0.5 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
0.5 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
0.1 |
GO:0016560 |
protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 |
4.5 |
GO:0043966 |
histone H3 acetylation(GO:0043966) |
| 0.1 |
1.2 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.1 |
0.1 |
GO:1905063 |
regulation of vascular smooth muscle cell differentiation(GO:1905063) |
| 0.1 |
0.5 |
GO:0043314 |
negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.1 |
0.1 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.1 |
0.2 |
GO:0060648 |
mammary gland bud morphogenesis(GO:0060648) |
| 0.1 |
0.2 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.1 |
0.8 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.1 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.1 |
0.9 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.1 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.1 |
0.2 |
GO:1904380 |
endoplasmic reticulum mannose trimming(GO:1904380) |
| 0.1 |
0.1 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 |
0.9 |
GO:2000353 |
positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 |
2.1 |
GO:1902743 |
regulation of lamellipodium organization(GO:1902743) |
| 0.1 |
0.5 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 |
0.3 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.1 |
0.3 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.1 |
0.1 |
GO:0034111 |
negative regulation of homotypic cell-cell adhesion(GO:0034111) |
| 0.1 |
2.5 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.1 |
1.4 |
GO:2000816 |
negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
| 0.1 |
0.3 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.1 |
0.1 |
GO:0060795 |
cell fate commitment involved in formation of primary germ layer(GO:0060795) |
| 0.1 |
0.4 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
0.3 |
GO:0061032 |
visceral serous pericardium development(GO:0061032) |
| 0.1 |
0.7 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 |
0.3 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) |
| 0.1 |
0.3 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.1 |
1.3 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
0.3 |
GO:0042487 |
regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.1 |
0.5 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
| 0.1 |
0.4 |
GO:2000172 |
regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) regulation of branching morphogenesis of a nerve(GO:2000172) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.1 |
0.3 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.1 |
0.4 |
GO:0034501 |
protein localization to kinetochore(GO:0034501) |
| 0.1 |
0.8 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
0.1 |
GO:0070266 |
necroptotic process(GO:0070266) |
| 0.1 |
2.9 |
GO:0060976 |
coronary vasculature development(GO:0060976) |
| 0.1 |
0.5 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
0.4 |
GO:0060398 |
regulation of growth hormone receptor signaling pathway(GO:0060398) |
| 0.1 |
0.4 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.1 |
0.4 |
GO:0042474 |
middle ear morphogenesis(GO:0042474) |
| 0.1 |
0.2 |
GO:0008355 |
olfactory learning(GO:0008355) |
| 0.1 |
0.4 |
GO:0072757 |
cellular response to camptothecin(GO:0072757) |
| 0.1 |
0.2 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 |
0.5 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.1 |
0.3 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
0.3 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
0.3 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 |
0.9 |
GO:0033292 |
T-tubule organization(GO:0033292) |
| 0.1 |
0.3 |
GO:2001170 |
negative regulation of ATP biosynthetic process(GO:2001170) |
| 0.1 |
1.1 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.1 |
0.2 |
GO:0060677 |
ureteric bud elongation(GO:0060677) |
| 0.1 |
0.1 |
GO:0048302 |
regulation of isotype switching to IgG isotypes(GO:0048302) |
| 0.1 |
0.1 |
GO:0048339 |
paraxial mesoderm development(GO:0048339) |
| 0.1 |
0.3 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.2 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.1 |
1.7 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.1 |
1.2 |
GO:0009303 |
rRNA transcription(GO:0009303) |
| 0.1 |
0.3 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.1 |
GO:0003419 |
growth plate cartilage chondrocyte proliferation(GO:0003419) |
| 0.1 |
0.1 |
GO:1901989 |
positive regulation of cell cycle phase transition(GO:1901989) |
| 0.1 |
0.1 |
GO:0061548 |
ganglion development(GO:0061548) |
| 0.1 |
0.1 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.1 |
0.3 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.1 |
0.1 |
GO:0072395 |
signal transduction involved in cell cycle checkpoint(GO:0072395) signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.1 |
0.4 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.1 |
0.2 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.1 |
0.2 |
GO:0001865 |
NK T cell differentiation(GO:0001865) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.1 |
0.4 |
GO:0010359 |
regulation of anion channel activity(GO:0010359) |
| 0.1 |
0.3 |
GO:0032053 |
ciliary basal body organization(GO:0032053) |
| 0.1 |
0.1 |
GO:0060442 |
branching involved in prostate gland morphogenesis(GO:0060442) |
| 0.1 |
0.7 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.1 |
0.4 |
GO:0006415 |
translational termination(GO:0006415) |
| 0.1 |
0.5 |
GO:0060338 |
regulation of type I interferon-mediated signaling pathway(GO:0060338) positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.1 |
0.3 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.1 |
0.1 |
GO:0071816 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
0.3 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.1 |
2.5 |
GO:0007026 |
negative regulation of microtubule depolymerization(GO:0007026) |
| 0.1 |
0.5 |
GO:0000055 |
ribosomal large subunit export from nucleus(GO:0000055) |
| 0.1 |
0.7 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.1 |
3.8 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.1 |
0.2 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.6 |
GO:0036342 |
post-anal tail morphogenesis(GO:0036342) |
| 0.1 |
1.6 |
GO:1902042 |
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902042) |
| 0.1 |
0.2 |
GO:0030421 |
defecation(GO:0030421) |
| 0.1 |
1.3 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.1 |
0.4 |
GO:0009396 |
folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.1 |
0.1 |
GO:2000275 |
regulation of oxidative phosphorylation uncoupler activity(GO:2000275) |
| 0.1 |
0.6 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.2 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.1 |
0.1 |
GO:0060525 |
prostate glandular acinus development(GO:0060525) secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.1 |
0.8 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.1 |
0.2 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.1 |
GO:0051933 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
| 0.1 |
0.2 |
GO:0018158 |
protein oxidation(GO:0018158) |
| 0.1 |
0.2 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 |
0.2 |
GO:0006824 |
cobalt ion transport(GO:0006824) |
| 0.1 |
0.3 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.2 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) |
| 0.1 |
0.4 |
GO:0098734 |
protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.1 |
0.2 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
0.2 |
GO:0036216 |
response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 |
0.6 |
GO:0036297 |
interstrand cross-link repair(GO:0036297) |
| 0.1 |
0.3 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.1 |
1.0 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 |
0.5 |
GO:1902187 |
negative regulation of viral release from host cell(GO:1902187) |
| 0.1 |
0.4 |
GO:0042640 |
anagen(GO:0042640) |
| 0.1 |
0.5 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 |
0.8 |
GO:0000920 |
cell separation after cytokinesis(GO:0000920) |
| 0.1 |
0.2 |
GO:0035845 |
photoreceptor cell outer segment organization(GO:0035845) |
| 0.1 |
0.5 |
GO:0045540 |
regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.1 |
0.4 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.1 |
0.4 |
GO:0002318 |
myeloid progenitor cell differentiation(GO:0002318) |
| 0.1 |
0.8 |
GO:0010569 |
regulation of double-strand break repair via homologous recombination(GO:0010569) |
| 0.1 |
0.3 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
0.2 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.1 |
0.3 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.1 |
0.2 |
GO:0045830 |
positive regulation of isotype switching(GO:0045830) |
| 0.1 |
0.4 |
GO:0060297 |
regulation of sarcomere organization(GO:0060297) |
| 0.1 |
2.2 |
GO:0034723 |
DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.1 |
0.2 |
GO:1990046 |
positive regulation of mitochondrial DNA replication(GO:0090297) regulation of cardiolipin metabolic process(GO:1900208) positive regulation of cardiolipin metabolic process(GO:1900210) stress-induced mitochondrial fusion(GO:1990046) |
| 0.1 |
1.1 |
GO:0033235 |
positive regulation of protein sumoylation(GO:0033235) |
| 0.1 |
0.7 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.2 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
0.5 |
GO:0080009 |
mRNA methylation(GO:0080009) |
| 0.1 |
0.1 |
GO:0050942 |
positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
| 0.1 |
0.2 |
GO:0045404 |
positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
| 0.1 |
0.1 |
GO:0060923 |
cardiac muscle cell fate commitment(GO:0060923) |
| 0.1 |
0.9 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
0.9 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 |
1.2 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 |
0.1 |
GO:0052428 |
modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.1 |
1.2 |
GO:0032435 |
negative regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032435) |
| 0.1 |
0.1 |
GO:0030208 |
dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 |
0.5 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.1 |
0.1 |
GO:0016095 |
polyprenol catabolic process(GO:0016095) |
| 0.1 |
0.1 |
GO:0075136 |
response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
| 0.1 |
0.2 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.1 |
0.1 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.1 |
0.6 |
GO:1903298 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.1 |
0.1 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.1 |
0.6 |
GO:0009799 |
specification of symmetry(GO:0009799) |
| 0.1 |
0.2 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 0.1 |
0.4 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.1 |
0.3 |
GO:0015744 |
succinate transport(GO:0015744) |
| 0.1 |
0.2 |
GO:0030540 |
female genitalia development(GO:0030540) |
| 0.1 |
0.2 |
GO:0044829 |
positive regulation by host of viral genome replication(GO:0044829) |
| 0.1 |
0.8 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
0.8 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.1 |
0.2 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.1 |
0.7 |
GO:0010715 |
regulation of extracellular matrix disassembly(GO:0010715) |
| 0.1 |
0.1 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.1 |
0.2 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 |
0.2 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.1 |
0.1 |
GO:1904017 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.1 |
0.2 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.1 |
0.1 |
GO:0033210 |
leptin-mediated signaling pathway(GO:0033210) |
| 0.1 |
0.6 |
GO:0000188 |
inactivation of MAPK activity(GO:0000188) |
| 0.1 |
0.1 |
GO:0007588 |
excretion(GO:0007588) |
| 0.1 |
0.6 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
0.3 |
GO:0036289 |
peptidyl-serine autophosphorylation(GO:0036289) |
| 0.1 |
0.1 |
GO:0019405 |
alditol catabolic process(GO:0019405) |
| 0.1 |
0.4 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.5 |
GO:0021694 |
cerebellar Purkinje cell layer formation(GO:0021694) |
| 0.1 |
0.5 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.1 |
0.2 |
GO:0045136 |
development of secondary sexual characteristics(GO:0045136) |
| 0.1 |
0.3 |
GO:0003433 |
chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.1 |
0.7 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.1 |
0.4 |
GO:0042730 |
fibrinolysis(GO:0042730) |
| 0.1 |
0.1 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.1 |
0.4 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.1 |
0.1 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.3 |
GO:0090244 |
Wnt signaling pathway involved in somitogenesis(GO:0090244) |
| 0.1 |
0.3 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
0.3 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.1 |
0.2 |
GO:0097012 |
response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 |
0.1 |
GO:0001946 |
lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
| 0.1 |
0.1 |
GO:0035902 |
response to immobilization stress(GO:0035902) |
| 0.1 |
0.3 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.1 |
0.3 |
GO:0000578 |
embryonic axis specification(GO:0000578) |
| 0.1 |
0.1 |
GO:0070236 |
negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.1 |
0.1 |
GO:0002035 |
brain renin-angiotensin system(GO:0002035) |
| 0.1 |
0.5 |
GO:0060716 |
labyrinthine layer blood vessel development(GO:0060716) |
| 0.1 |
0.2 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.1 |
0.3 |
GO:0090666 |
scaRNA localization to Cajal body(GO:0090666) |
| 0.1 |
0.1 |
GO:0033762 |
response to glucagon(GO:0033762) |
| 0.1 |
0.3 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.1 |
0.1 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) |
| 0.1 |
0.3 |
GO:0061072 |
iris morphogenesis(GO:0061072) |
| 0.1 |
0.6 |
GO:0043277 |
apoptotic cell clearance(GO:0043277) |
| 0.1 |
0.5 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.1 |
0.1 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.1 |
GO:0032462 |
regulation of protein homooligomerization(GO:0032462) |
| 0.1 |
0.2 |
GO:1904738 |
vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
| 0.1 |
0.2 |
GO:0015882 |
L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
| 0.1 |
0.1 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.1 |
0.3 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.1 |
GO:0021544 |
subpallium development(GO:0021544) |
| 0.1 |
0.8 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.3 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 |
0.7 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.3 |
GO:1901070 |
guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.1 |
0.2 |
GO:1903214 |
regulation of protein targeting to mitochondrion(GO:1903214) |
| 0.1 |
0.4 |
GO:0043045 |
DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
| 0.1 |
0.7 |
GO:0018206 |
peptidyl-methionine modification(GO:0018206) |
| 0.1 |
0.1 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.1 |
0.7 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
1.0 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.2 |
GO:0070303 |
negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
| 0.1 |
0.3 |
GO:0051084 |
'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
| 0.1 |
0.3 |
GO:0051642 |
centrosome localization(GO:0051642) |
| 0.1 |
0.2 |
GO:0042473 |
outer ear morphogenesis(GO:0042473) |
| 0.1 |
0.4 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.1 |
0.2 |
GO:0016259 |
selenocysteine metabolic process(GO:0016259) |
| 0.1 |
0.1 |
GO:2001245 |
regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
| 0.1 |
5.3 |
GO:0051028 |
mRNA transport(GO:0051028) |
| 0.1 |
0.5 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.1 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.2 |
GO:1903748 |
regulation of mRNA modification(GO:0090365) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.1 |
0.1 |
GO:2000642 |
negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.1 |
0.1 |
GO:0050872 |
white fat cell differentiation(GO:0050872) |
| 0.1 |
1.1 |
GO:0030149 |
sphingolipid catabolic process(GO:0030149) |
| 0.1 |
0.4 |
GO:1900016 |
negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.1 |
1.6 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.1 |
GO:0051582 |
positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.1 |
0.4 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.1 |
0.3 |
GO:0045671 |
negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 |
0.3 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
0.2 |
GO:1902287 |
semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
| 0.1 |
0.2 |
GO:0009812 |
flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
| 0.1 |
0.3 |
GO:1904668 |
positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.1 |
0.1 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 0.1 |
0.2 |
GO:0060056 |
mammary gland involution(GO:0060056) |
| 0.1 |
0.2 |
GO:0019359 |
NAD biosynthetic process(GO:0009435) nicotinamide nucleotide biosynthetic process(GO:0019359) |
| 0.1 |
1.1 |
GO:0046677 |
response to antibiotic(GO:0046677) |
| 0.1 |
0.2 |
GO:0071670 |
smooth muscle cell chemotaxis(GO:0071670) |
| 0.1 |
0.3 |
GO:0060143 |
positive regulation of syncytium formation by plasma membrane fusion(GO:0060143) |
| 0.1 |
0.3 |
GO:2000786 |
positive regulation of autophagosome assembly(GO:2000786) |
| 0.1 |
0.2 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.1 |
0.1 |
GO:0042524 |
negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
| 0.1 |
0.4 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.1 |
0.2 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.1 |
0.4 |
GO:0061000 |
negative regulation of dendritic spine development(GO:0061000) |
| 0.1 |
0.1 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.1 |
0.4 |
GO:0000103 |
sulfate assimilation(GO:0000103) |
| 0.1 |
0.1 |
GO:0009110 |
vitamin biosynthetic process(GO:0009110) |
| 0.1 |
1.3 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 |
0.3 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
0.2 |
GO:0098787 |
mRNA cleavage involved in mRNA processing(GO:0098787) |
| 0.1 |
2.0 |
GO:0070613 |
regulation of protein processing(GO:0070613) |
| 0.1 |
0.3 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.1 |
0.2 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.1 |
0.2 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.1 |
0.1 |
GO:2000651 |
positive regulation of sodium ion transmembrane transport(GO:1902307) positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 |
0.2 |
GO:0007220 |
Notch receptor processing(GO:0007220) |
| 0.1 |
0.1 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.1 |
0.3 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.1 |
0.5 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.1 |
0.2 |
GO:0046628 |
positive regulation of insulin receptor signaling pathway(GO:0046628) |
| 0.1 |
0.1 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.1 |
0.8 |
GO:0010629 |
negative regulation of gene expression(GO:0010629) |
| 0.1 |
0.3 |
GO:0006924 |
activation-induced cell death of T cells(GO:0006924) |
| 0.1 |
0.1 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.1 |
0.1 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.1 |
0.6 |
GO:0043687 |
post-translational protein modification(GO:0043687) |
| 0.1 |
0.2 |
GO:0003091 |
renal water homeostasis(GO:0003091) ATF6-mediated unfolded protein response(GO:0036500) |
| 0.1 |
0.2 |
GO:0009449 |
gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.1 |
0.1 |
GO:0090399 |
replicative senescence(GO:0090399) |
| 0.1 |
0.2 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.1 |
0.1 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.1 |
1.0 |
GO:0006084 |
acetyl-CoA metabolic process(GO:0006084) |
| 0.1 |
0.1 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.1 |
0.1 |
GO:0010961 |
cellular magnesium ion homeostasis(GO:0010961) |
| 0.1 |
0.6 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.1 |
0.1 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.1 |
0.1 |
GO:0030997 |
regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 |
0.2 |
GO:1902036 |
regulation of hematopoietic stem cell differentiation(GO:1902036) |
| 0.1 |
0.2 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.1 |
0.1 |
GO:2000370 |
positive regulation of clathrin-mediated endocytosis(GO:2000370) |
| 0.1 |
0.8 |
GO:0034198 |
cellular response to amino acid starvation(GO:0034198) |
| 0.1 |
0.2 |
GO:0030728 |
ovulation(GO:0030728) |
| 0.1 |
0.1 |
GO:0060279 |
positive regulation of ovulation(GO:0060279) |
| 0.0 |
0.3 |
GO:0090136 |
epithelial cell-cell adhesion(GO:0090136) |
| 0.0 |
0.1 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.0 |
0.1 |
GO:0001927 |
exocyst assembly(GO:0001927) |
| 0.0 |
0.0 |
GO:1902807 |
negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.0 |
0.8 |
GO:0051438 |
regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.0 |
0.1 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.0 |
0.3 |
GO:0034629 |
cellular protein complex localization(GO:0034629) |
| 0.0 |
0.2 |
GO:0006678 |
glucosylceramide metabolic process(GO:0006678) |
| 0.0 |
0.3 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.0 |
0.0 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.0 |
0.4 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.0 |
0.1 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.0 |
0.1 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.0 |
0.1 |
GO:0006309 |
apoptotic DNA fragmentation(GO:0006309) |
| 0.0 |
0.0 |
GO:0051567 |
histone H3-K9 methylation(GO:0051567) histone H3-K9 modification(GO:0061647) |
| 0.0 |
0.8 |
GO:0043627 |
response to estrogen(GO:0043627) |
| 0.0 |
0.0 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.0 |
0.0 |
GO:0040019 |
positive regulation of embryonic development(GO:0040019) |
| 0.0 |
0.1 |
GO:0009051 |
pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.0 |
0.5 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 |
1.1 |
GO:1902749 |
regulation of cell cycle G2/M phase transition(GO:1902749) |
| 0.0 |
0.5 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.0 |
0.1 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.0 |
0.0 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.0 |
0.4 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.0 |
0.2 |
GO:1903779 |
regulation of cardiac conduction(GO:1903779) |
| 0.0 |
0.2 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.0 |
0.1 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.0 |
0.0 |
GO:1902956 |
regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
| 0.0 |
0.1 |
GO:2000641 |
regulation of early endosome to late endosome transport(GO:2000641) |
| 0.0 |
0.3 |
GO:0031062 |
positive regulation of histone methylation(GO:0031062) |
| 0.0 |
0.2 |
GO:1903071 |
positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.0 |
0.4 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.0 |
0.2 |
GO:0021794 |
thalamus development(GO:0021794) |
| 0.0 |
0.1 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.0 |
0.1 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.0 |
0.4 |
GO:0006706 |
steroid catabolic process(GO:0006706) |
| 0.0 |
0.1 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.0 |
0.3 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.0 |
0.2 |
GO:0006221 |
pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.0 |
0.1 |
GO:0001736 |
establishment of planar polarity(GO:0001736) establishment of tissue polarity(GO:0007164) |
| 0.0 |
0.1 |
GO:0031960 |
response to corticosteroid(GO:0031960) response to glucocorticoid(GO:0051384) |
| 0.0 |
0.0 |
GO:0046364 |
monosaccharide biosynthetic process(GO:0046364) |
| 0.0 |
0.2 |
GO:0031424 |
keratinization(GO:0031424) |
| 0.0 |
0.4 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 0.0 |
0.6 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.0 |
0.2 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.0 |
0.1 |
GO:0016553 |
adenosine to inosine editing(GO:0006382) base conversion or substitution editing(GO:0016553) |
| 0.0 |
0.4 |
GO:0051016 |
barbed-end actin filament capping(GO:0051016) |
| 0.0 |
0.1 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.0 |
0.3 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.2 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.0 |
0.2 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.0 |
0.5 |
GO:0031397 |
negative regulation of protein ubiquitination(GO:0031397) |
| 0.0 |
0.1 |
GO:0070889 |
platelet alpha granule organization(GO:0070889) |
| 0.0 |
0.1 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 |
0.0 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.0 |
0.5 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.0 |
0.1 |
GO:0006517 |
protein deglycosylation(GO:0006517) |
| 0.0 |
0.1 |
GO:0072429 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.0 |
0.2 |
GO:0032506 |
cytokinetic process(GO:0032506) |
| 0.0 |
0.1 |
GO:0015960 |
diadenosine polyphosphate metabolic process(GO:0015959) diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.0 |
0.0 |
GO:0035509 |
negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.0 |
0.3 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.0 |
0.3 |
GO:0002716 |
negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.0 |
0.0 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 |
0.1 |
GO:0038026 |
reelin-mediated signaling pathway(GO:0038026) |
| 0.0 |
0.4 |
GO:0051131 |
chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 |
0.1 |
GO:0045779 |
negative regulation of bone resorption(GO:0045779) |
| 0.0 |
0.0 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.0 |
0.6 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.2 |
GO:0045638 |
negative regulation of myeloid cell differentiation(GO:0045638) |
| 0.0 |
0.3 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.0 |
1.2 |
GO:0006911 |
phagocytosis, engulfment(GO:0006911) |
| 0.0 |
0.1 |
GO:0016199 |
axon midline choice point recognition(GO:0016199) |
| 0.0 |
0.3 |
GO:0042448 |
progesterone metabolic process(GO:0042448) |
| 0.0 |
0.1 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.0 |
0.1 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.2 |
GO:1903846 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.0 |
0.6 |
GO:0046460 |
triglyceride biosynthetic process(GO:0019432) neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
| 0.0 |
0.4 |
GO:0050892 |
intestinal absorption(GO:0050892) |
| 0.0 |
0.1 |
GO:0060287 |
epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.0 |
0.1 |
GO:0090209 |
negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.0 |
0.0 |
GO:0010886 |
positive regulation of cholesterol storage(GO:0010886) |
| 0.0 |
0.4 |
GO:2000380 |
regulation of mesoderm development(GO:2000380) |
| 0.0 |
0.2 |
GO:0032401 |
establishment of melanosome localization(GO:0032401) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.3 |
GO:0010390 |
histone monoubiquitination(GO:0010390) |
| 0.0 |
2.4 |
GO:1903955 |
positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.0 |
0.2 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.1 |
GO:1901552 |
positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
| 0.0 |
0.3 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.0 |
0.4 |
GO:0090435 |
protein localization to nuclear envelope(GO:0090435) |
| 0.0 |
0.0 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.0 |
0.1 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.0 |
0.4 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.0 |
0.0 |
GO:0090177 |
establishment of planar polarity involved in neural tube closure(GO:0090177) |
| 0.0 |
0.4 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.0 |
0.1 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.0 |
0.2 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
1.3 |
GO:0009725 |
response to hormone(GO:0009725) |
| 0.0 |
1.1 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.5 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.0 |
0.2 |
GO:0034982 |
mitochondrial protein processing(GO:0034982) |
| 0.0 |
0.1 |
GO:1903624 |
regulation of apoptotic DNA fragmentation(GO:1902510) regulation of DNA catabolic process(GO:1903624) |
| 0.0 |
0.2 |
GO:0002467 |
germinal center formation(GO:0002467) |
| 0.0 |
0.4 |
GO:0071539 |
protein localization to centrosome(GO:0071539) |
| 0.0 |
0.1 |
GO:0039532 |
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.0 |
0.1 |
GO:0010890 |
positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 |
0.3 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.0 |
0.3 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.2 |
GO:0090344 |
negative regulation of cell aging(GO:0090344) |
| 0.0 |
0.2 |
GO:1902775 |
mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.0 |
0.1 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.0 |
0.1 |
GO:0051569 |
regulation of histone H3-K4 methylation(GO:0051569) |
| 0.0 |
1.5 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.0 |
0.2 |
GO:0061515 |
myeloid cell development(GO:0061515) |
| 0.0 |
0.0 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.0 |
0.3 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.0 |
0.1 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.0 |
0.1 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.0 |
0.3 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.3 |
GO:0060766 |
negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.0 |
0.5 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.2 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.0 |
0.1 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.0 |
0.3 |
GO:0006684 |
sphingomyelin metabolic process(GO:0006684) |
| 0.0 |
0.2 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.0 |
0.5 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.0 |
0.1 |
GO:0090103 |
cochlea morphogenesis(GO:0090103) |
| 0.0 |
0.3 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.0 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.0 |
0.1 |
GO:0046835 |
carbohydrate phosphorylation(GO:0046835) |
| 0.0 |
0.1 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.0 |
0.5 |
GO:2000117 |
negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.0 |
0.1 |
GO:0033160 |
positive regulation of protein import into nucleus, translocation(GO:0033160) |
| 0.0 |
0.2 |
GO:0006103 |
2-oxoglutarate metabolic process(GO:0006103) |
| 0.0 |
0.3 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.0 |
0.2 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.0 |
0.3 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 |
0.0 |
GO:0046122 |
purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.0 |
0.0 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.0 |
1.5 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.0 |
0.2 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.0 |
0.1 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.0 |
0.3 |
GO:0010883 |
regulation of lipid storage(GO:0010883) |
| 0.0 |
0.1 |
GO:0050858 |
negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
| 0.0 |
0.8 |
GO:0000387 |
spliceosomal snRNP assembly(GO:0000387) |
| 0.0 |
0.3 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
0.0 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.0 |
0.1 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.0 |
0.2 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.0 |
0.1 |
GO:1903378 |
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.0 |
0.1 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
0.7 |
GO:0046834 |
lipid phosphorylation(GO:0046834) |
| 0.0 |
2.1 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.0 |
0.2 |
GO:0044275 |
cellular carbohydrate catabolic process(GO:0044275) |
| 0.0 |
0.2 |
GO:1903352 |
ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
| 0.0 |
0.5 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.0 |
0.1 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.0 |
1.2 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.1 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.0 |
0.2 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.2 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.0 |
0.3 |
GO:0090004 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.0 |
0.2 |
GO:0002208 |
somatic recombination of immunoglobulin genes involved in immune response(GO:0002204) somatic diversification of immunoglobulins involved in immune response(GO:0002208) isotype switching(GO:0045190) |
| 0.0 |
0.8 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.0 |
0.2 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.0 |
0.4 |
GO:0060711 |
labyrinthine layer development(GO:0060711) |
| 0.0 |
0.9 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.0 |
0.6 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
0.1 |
GO:0010039 |
response to iron ion(GO:0010039) |
| 0.0 |
0.1 |
GO:0001834 |
trophectodermal cell proliferation(GO:0001834) |
| 0.0 |
0.7 |
GO:0032212 |
positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
| 0.0 |
0.1 |
GO:0014043 |
negative regulation of neuron maturation(GO:0014043) vein smooth muscle contraction(GO:0014826) |
| 0.0 |
0.2 |
GO:0001675 |
acrosome assembly(GO:0001675) |
| 0.0 |
1.5 |
GO:0046847 |
filopodium assembly(GO:0046847) |
| 0.0 |
0.1 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.1 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 |
0.4 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.0 |
0.1 |
GO:0060330 |
regulation of response to interferon-gamma(GO:0060330) |
| 0.0 |
0.2 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
0.2 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) synaptonemal complex organization(GO:0070193) |
| 0.0 |
0.4 |
GO:0000394 |
RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
| 0.0 |
0.1 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.0 |
0.4 |
GO:0008299 |
isoprenoid biosynthetic process(GO:0008299) |
| 0.0 |
0.0 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.0 |
0.2 |
GO:0006817 |
phosphate ion transport(GO:0006817) |
| 0.0 |
0.2 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.0 |
0.0 |
GO:0090148 |
membrane fission(GO:0090148) |
| 0.0 |
0.4 |
GO:0006353 |
DNA-templated transcription, termination(GO:0006353) |
| 0.0 |
0.2 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.0 |
0.2 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) |
| 0.0 |
0.3 |
GO:0031987 |
locomotion involved in locomotory behavior(GO:0031987) |
| 0.0 |
0.2 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.0 |
0.1 |
GO:0030071 |
regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
| 0.0 |
0.3 |
GO:0022617 |
extracellular matrix disassembly(GO:0022617) |
| 0.0 |
0.7 |
GO:0030488 |
tRNA methylation(GO:0030488) |
| 0.0 |
0.4 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.1 |
GO:0060147 |
regulation of posttranscriptional gene silencing(GO:0060147) regulation of gene silencing by RNA(GO:0060966) |
| 0.0 |
0.1 |
GO:0048484 |
enteric nervous system development(GO:0048484) |
| 0.0 |
0.6 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.0 |
0.1 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.0 |
0.1 |
GO:2000116 |
regulation of cysteine-type endopeptidase activity(GO:2000116) |
| 0.0 |
0.1 |
GO:1900242 |
regulation of synaptic vesicle endocytosis(GO:1900242) |
| 0.0 |
0.3 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.0 |
0.0 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.0 |
0.3 |
GO:0048384 |
retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 |
0.1 |
GO:0006451 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.1 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) positive regulation of voltage-gated potassium channel activity(GO:1903818) |
| 0.0 |
0.1 |
GO:0051156 |
glucose 6-phosphate metabolic process(GO:0051156) |
| 0.0 |
0.1 |
GO:1902108 |
regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902108) |
| 0.0 |
0.1 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.0 |
0.1 |
GO:0051031 |
tRNA transport(GO:0051031) |
| 0.0 |
0.1 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.1 |
GO:0006420 |
arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 |
0.5 |
GO:0007052 |
mitotic spindle organization(GO:0007052) |
| 0.0 |
0.1 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.0 |
0.1 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.0 |
0.2 |
GO:0010664 |
negative regulation of striated muscle cell apoptotic process(GO:0010664) |
| 0.0 |
0.1 |
GO:0070474 |
positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.0 |
0.3 |
GO:0014741 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
| 0.0 |
0.5 |
GO:0000281 |
mitotic cytokinesis(GO:0000281) |
| 0.0 |
0.1 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 |
0.1 |
GO:1990776 |
cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
| 0.0 |
0.1 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.0 |
0.0 |
GO:0000821 |
regulation of arginine metabolic process(GO:0000821) |
| 0.0 |
0.0 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.0 |
0.4 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.0 |
0.2 |
GO:0006220 |
pyrimidine nucleotide metabolic process(GO:0006220) |
| 0.0 |
0.2 |
GO:2001197 |
regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.0 |
0.1 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 |
0.2 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.0 |
0.2 |
GO:0070979 |
protein K11-linked ubiquitination(GO:0070979) |
| 0.0 |
0.4 |
GO:1902622 |
regulation of neutrophil migration(GO:1902622) |
| 0.0 |
0.2 |
GO:0006490 |
oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
| 0.0 |
0.1 |
GO:0017014 |
protein nitrosylation(GO:0017014) |
| 0.0 |
0.0 |
GO:0070827 |
chromatin maintenance(GO:0070827) |
| 0.0 |
0.0 |
GO:0032914 |
positive regulation of transforming growth factor beta1 production(GO:0032914) |
| 0.0 |
0.0 |
GO:0032400 |
melanosome localization(GO:0032400) |
| 0.0 |
0.1 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.0 |
0.9 |
GO:1902017 |
regulation of cilium assembly(GO:1902017) |
| 0.0 |
0.3 |
GO:0051497 |
negative regulation of stress fiber assembly(GO:0051497) |
| 0.0 |
0.1 |
GO:0009226 |
nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.0 |
0.1 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.0 |
0.3 |
GO:0030520 |
intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.0 |
0.1 |
GO:0046688 |
response to copper ion(GO:0046688) |
| 0.0 |
0.1 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.0 |
0.1 |
GO:0031145 |
anaphase-promoting complex-dependent catabolic process(GO:0031145) |
| 0.0 |
0.3 |
GO:0007019 |
microtubule depolymerization(GO:0007019) |
| 0.0 |
0.1 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.0 |
0.2 |
GO:0048854 |
brain morphogenesis(GO:0048854) |
| 0.0 |
0.1 |
GO:0010822 |
positive regulation of mitochondrion organization(GO:0010822) |
| 0.0 |
0.0 |
GO:0032000 |
positive regulation of fatty acid beta-oxidation(GO:0032000) |
| 0.0 |
0.1 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.0 |
1.1 |
GO:0016125 |
sterol metabolic process(GO:0016125) |
| 0.0 |
0.0 |
GO:0097237 |
cellular response to toxic substance(GO:0097237) |
| 0.0 |
0.1 |
GO:0098838 |
reduced folate transmembrane transport(GO:0098838) |
| 0.0 |
0.0 |
GO:0006059 |
hexitol metabolic process(GO:0006059) |
| 0.0 |
0.1 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.0 |
0.1 |
GO:0045019 |
negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.0 |
0.1 |
GO:2000109 |
macrophage apoptotic process(GO:0071888) protein sialylation(GO:1990743) regulation of macrophage apoptotic process(GO:2000109) negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.0 |
0.5 |
GO:0045670 |
regulation of osteoclast differentiation(GO:0045670) |
| 0.0 |
0.3 |
GO:0032467 |
positive regulation of cytokinesis(GO:0032467) |
| 0.0 |
0.1 |
GO:0001821 |
histamine secretion(GO:0001821) histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.0 |
0.1 |
GO:0033273 |
response to vitamin(GO:0033273) |
| 0.0 |
0.2 |
GO:0035025 |
positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.0 |
0.1 |
GO:0071205 |
protein localization to juxtaparanode region of axon(GO:0071205) |
| 0.0 |
0.1 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.0 |
0.1 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.0 |
0.0 |
GO:2000407 |
T cell extravasation(GO:0072683) regulation of T cell extravasation(GO:2000407) positive regulation of T cell extravasation(GO:2000409) |
| 0.0 |
0.0 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.1 |
GO:0018022 |
peptidyl-lysine methylation(GO:0018022) |
| 0.0 |
0.0 |
GO:0032570 |
response to progesterone(GO:0032570) |
| 0.0 |
0.1 |
GO:1900060 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.0 |
0.1 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.0 |
0.1 |
GO:0002313 |
mature B cell differentiation involved in immune response(GO:0002313) |
| 0.0 |
0.2 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.1 |
GO:0003351 |
epithelial cilium movement(GO:0003351) |
| 0.0 |
0.1 |
GO:0046006 |
regulation of activated T cell proliferation(GO:0046006) |
| 0.0 |
0.0 |
GO:0030104 |
water homeostasis(GO:0030104) regulation of water loss via skin(GO:0033561) |
| 0.0 |
0.3 |
GO:0001890 |
placenta development(GO:0001890) |
| 0.0 |
0.1 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 |
0.4 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
0.0 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.0 |
0.1 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.0 |
0.1 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.0 |
0.1 |
GO:0032509 |
endosome transport via multivesicular body sorting pathway(GO:0032509) |
| 0.0 |
0.2 |
GO:0006913 |
nucleocytoplasmic transport(GO:0006913) |
| 0.0 |
0.1 |
GO:0043507 |
positive regulation of JUN kinase activity(GO:0043507) |
| 0.0 |
0.5 |
GO:0000725 |
double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
| 0.0 |
0.2 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.0 |
0.1 |
GO:2000678 |
negative regulation of transcription regulatory region DNA binding(GO:2000678) |
| 0.0 |
0.0 |
GO:0033033 |
negative regulation of myeloid cell apoptotic process(GO:0033033) |
| 0.0 |
0.1 |
GO:0031060 |
regulation of histone methylation(GO:0031060) |
| 0.0 |
0.1 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 |
0.1 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.0 |
0.1 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.0 |
0.3 |
GO:0000186 |
activation of MAPKK activity(GO:0000186) |
| 0.0 |
0.1 |
GO:0001990 |
regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.0 |
0.0 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.0 |
0.2 |
GO:0018342 |
protein prenylation(GO:0018342) prenylation(GO:0097354) |
| 0.0 |
0.1 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.0 |
0.6 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.0 |
0.2 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.0 |
GO:0048144 |
fibroblast proliferation(GO:0048144) |
| 0.0 |
0.1 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
0.1 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.0 |
0.0 |
GO:0042403 |
thyroid hormone metabolic process(GO:0042403) |
| 0.0 |
0.1 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.0 |
0.0 |
GO:0001887 |
selenium compound metabolic process(GO:0001887) |
| 0.0 |
0.1 |
GO:0001937 |
negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.0 |
0.3 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.0 |
0.0 |
GO:0006498 |
N-terminal protein lipidation(GO:0006498) |
| 0.0 |
0.0 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.0 |
0.2 |
GO:0031290 |
retinal ganglion cell axon guidance(GO:0031290) |
| 0.0 |
0.2 |
GO:0048747 |
muscle fiber development(GO:0048747) |
| 0.0 |
0.0 |
GO:1903541 |
regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
| 0.0 |
0.1 |
GO:0048194 |
Golgi vesicle budding(GO:0048194) |
| 0.0 |
0.2 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.0 |
GO:0098543 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.0 |
0.0 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.0 |
0.2 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.0 |
0.3 |
GO:0000910 |
cytokinesis(GO:0000910) |
| 0.0 |
0.1 |
GO:0007602 |
phototransduction(GO:0007602) |
| 0.0 |
0.0 |
GO:0050931 |
pigment cell differentiation(GO:0050931) |
| 0.0 |
0.1 |
GO:0033567 |
DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.0 |
0.0 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.0 |
0.0 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.0 |
0.0 |
GO:0045602 |
negative regulation of endothelial cell differentiation(GO:0045602) |
| 0.0 |
0.1 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.0 |
0.0 |
GO:0060455 |
regulation of gastric acid secretion(GO:0060453) negative regulation of gastric acid secretion(GO:0060455) |
| 0.0 |
0.0 |
GO:0019441 |
tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.0 |
0.1 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.0 |
0.1 |
GO:0030316 |
osteoclast differentiation(GO:0030316) |
| 0.0 |
0.1 |
GO:0019430 |
removal of superoxide radicals(GO:0019430) cellular oxidant detoxification(GO:0098869) |
| 0.0 |
0.0 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
0.2 |
GO:0033209 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) |
| 0.0 |
0.0 |
GO:0030836 |
positive regulation of actin filament depolymerization(GO:0030836) positive regulation of protein depolymerization(GO:1901881) |
| 0.0 |
0.1 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.0 |
0.1 |
GO:0042594 |
response to starvation(GO:0042594) |
| 0.0 |
0.0 |
GO:0008347 |
glial cell migration(GO:0008347) |
| 0.0 |
0.0 |
GO:0003014 |
renal system process(GO:0003014) |
| 0.0 |
0.1 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.0 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.0 |
0.1 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 |
0.0 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.0 |
0.1 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.0 |
0.0 |
GO:0001672 |
regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.0 |
0.2 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.0 |
0.1 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.0 |
0.1 |
GO:0031440 |
regulation of mRNA 3'-end processing(GO:0031440) |
| 0.0 |
0.0 |
GO:1903077 |
negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.0 |
0.2 |
GO:0032436 |
positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
| 0.0 |
0.0 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.0 |
0.0 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.0 |
0.0 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.1 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 |
0.1 |
GO:0010524 |
positive regulation of calcium ion transport into cytosol(GO:0010524) |
| 0.0 |
0.0 |
GO:0070649 |
meiotic chromosome movement towards spindle pole(GO:0016344) meiotic cytokinesis(GO:0033206) chromosome movement towards spindle pole(GO:0051305) formin-nucleated actin cable assembly(GO:0070649) |
| 0.0 |
0.0 |
GO:0001541 |
ovarian follicle development(GO:0001541) |
| 0.0 |
0.0 |
GO:0032788 |
saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
| 0.0 |
0.1 |
GO:0010633 |
negative regulation of epithelial cell migration(GO:0010633) |
| 0.0 |
0.0 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.0 |
0.3 |
GO:0008630 |
intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.0 |
0.1 |
GO:0035058 |
nonmotile primary cilium assembly(GO:0035058) |
| 0.0 |
0.2 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.6 |
GO:0000209 |
protein polyubiquitination(GO:0000209) |
| 0.0 |
0.1 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
